Empagliflozin 10 MG ( DrugBank: Empagliflozin )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
58	Hypertrophic cardiomyopathy	1
97	Ulcerative colitis	1

58. Hypertrophic cardiomyopathy

---

Clinical trials : 126 /  Drugs : 135 - (DrugBank : 42) / Drug target genes : 46 - Drug target pathways : 162

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05182658 (ClinicalTrials.gov)	June 1, 2022	21/12/2021	Empagliflozin in Hypertrophic Cardiomyopathy	The Use of Empagliflozin in Patients With Hypertrophic Cardiomyopathy	Hypertrophic Cardiomyopathy;Heart Failure	Drug: Empagliflozin 10 MG;Drug: Placebo	Institute of Cardiology, Warsaw, Poland	Medical University of Bialystok;University of Eastern Finland;Amsterdam UMC, location VUmc	Not yet recruiting	18 Years	70 Years	All	250	Phase 3	Poland

97. Ulcerative colitis

---

Clinical trials : 2,630 /  Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05058417 (ClinicalTrials.gov)	October 1, 2021	16/9/2021	Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis	Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis	Ulcerative Colitis	Drug: Empagliflozin 10 MG;Drug: Placebo	Sadat City University	NULL	Recruiting	18 Years	60 Years	All	50	Phase 2	Egypt